Innovations in vaccine technology

&

By using DNA vaccines, it may be possible to give increased protection against influenza than can currently be achieved. DNA vaccines are a relatively new concept and their potential has been demonstrated in preclinical studies. Another recent innovation is the use of recombinant BCG (rBCG) as a vaccine vehicle. rBCG has the advantage of being a strong immunostimulant, and, when applied to mucosal surfaces, elicits both systemic and mucosal immune responses. These 2 developments in vaccine technology were discussed at the IBC 2nd Annual Conference on ‘ New Advances in Vaccine Technologies and Applications ’ [ Bethesda, US; February 1995 ].